Atezolizumab in a first-line setting in non-small-cell lung cancer with high PD-L1 expression

xlomafota13 shared this article with you from Inoreader Atezolizumab in a first-line setting in non-small-cell lung cancer with high PD-L1 expression Via Association française pour l'étude du cancer Bull Cancer. 2021 Sep 28:S0007-4551(21)00310-6. doi: 10.1016/j.bulcan.2021.06.011. Online ahead of print. NO ABSTRACT PMID:34598788 | DOI:10.1016/j.bulcan.2021.06.011 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.